Aastrom Biosciences, Inc.

Address

Domio'S Farms. Lobby L, 24 Frank Lloyd Wright Dr.
Ann Arbor, MI, 48105

Information

DUNS:
# of Employees: N/A

Ownership Information

Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N

Award Charts




Award Listing

  1. Clinical-scale Production of Osteoprogenitor Cells

    Amount: $743,066.00

    DESCRIPTION (provided by applicant): Due to morbidity and limited amounts of material, alternatives to autologous grafts for bone repair are desirable. Cells within the bone marrow are known to posses ...

    SBIRPhase II2005Department of Health and Human Services
  2. Clinical Human Cell Production System for Broad Use

    Amount: $798,266.00

    The therapeutic potential of patient-specific cultured cells continues to rapidly grow for a range of medical needs, such as regenerative repair of damaged tissue, cancer, and infectious diseases. As ...

    SBIRPhase II2005Department of Health and Human Services
  3. Dendritic Cell Subset for Enhanced Cancer Vaccine

    Amount: $109,586.00

    DESCRIPTION (provided by applicant): Tumor antigen primed dendritic cells (DCs) are under widespread clinical evaluation for immunotherapy of multiple forms of cancer. Emerging evidence suggests that ...

    SBIRPhase I2004Department of Health and Human Services
  4. Bioreactor for Enhanced T-cell Based Therapy of Melanoma

    Amount: $124,154.00

    DESCRIPTION (provided by applicant): Malignant melanoma is a significant and deadly form of cancer worldwide. Emerging evidence has shown that melanoma cells express tumor-associated antigens that ar ...

    SBIRPhase I2004Department of Health and Human Services
  5. Clinical Human Cell Production System for Broad Use

    Amount: $101,452.00

    DESCRIPTION (provided by applicant): As a result of growing evidence of their therapeutic potential in cancer, infectious diseases, and tissue repair, there is an enormous increase in the research an ...

    SBIRPhase I2003Department of Health and Human Services
  6. Enhanced Tumor Antigen Priming of Dendritic Cell Vaccine

    Amount: $101,262.00

    DESCRIPTION (provided by the applicant): Dendritic cells have been shown to initiate, regulate, and direct cytolytic T-cell-mediated immune responses against tumor antigens in human patients. Recent ...

    SBIRPhase I2003Department of Health and Human Services
  7. Automated Perfused Culture Process for Adult Stem Cells

    Amount: $442,555.00

    DESCRIPTION (provided by applicant): Adherent mesenchymal cell populations derived from bone marrow (BM) have the capability of differentiating into multiple cell lineages in vitro and in vivo. The po ...

    SBIRPhase I2003Department of Health and Human Services
  8. Clinical-scale Production of Osteoprogenitor Cells

    Amount: $110,062.00

    DESCRIPTION (provided by applicant): Due to morbidity and limited amounts of material, alternatives to autologous grafts for bone repair are desirable. Mixtures of marrow stromal cells (MSC) and carr ...

    SBIRPhase I2003Department of Health and Human Services
  9. Automated Large-Scale Production of Endothelial Cells

    Amount: $99,840.00

    DESCRIPTION (provided by applicant): Treatment of ischemia by administration of bone marrow (BM)-derived endothelial progenitor cells (EPC) or ex vivo expanded EPC populations has been shown to enhanc ...

    SBIRPhase I2003Department of Health and Human Services
  10. N/A

    Amount: $0.00

    N/A

    SBIRPhase I2000Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government